Syncore Biotechnology to Participate at the Biotech Showcase 2018 Conference
Syncore Biotechnology will attend the Biotech Showcase 2018 Conference [...]
SynCore Biotechnology to Participate at the BIO-Europe 2017 – 23rd Annual International Partnering Conference
SynCore Biotechnology announced that the company will attend the [...]
SynCore Biotechnology Receives Investigational New Drug (IND) Clearance of SB05 PC by the Taiwan Food and Drug Administration (TFDA) to Conduct a Phase III Clinical Trial for the Treatment of Metastatic Adenocarcinoma of the Pancreas
Investigational New Drug (IND) clearance from TFDA represents a [...]
SynCore Bio to present the Phase I study of SB01 at ASCO 2017
SynCore Biotechnology Co., Ltd. (SynCore) is selected to present [...]
SynCore Biotechnology Receives Investigational New Drug (IND) Clearance of SB05 PC by the US Food and Drug Administration (FDA) to Conduct a Phase III Clinical Trial for the Treatment of Metastatic Adenocarcinoma of the Pancreas
• Investigational New Drug (IND) clearance from US FDA [...]
SynCore Bio is selected to present the Phase I study data of new anti-cancer molecule SB01 at ASCO 2017
SynCore Bio is selected to present the Phase I [...]
2017 Sinphar Bio-Forum – Cardiovascular Disease Management
On January 13th of this year, Sinphar Group held [...]